|
In order to receive continuing support from the National Institute for Health (NIH), we are required to provide bio-safety review and oversight for research involving recombinant DNA.
When we receive NIH funding for research involving recombinant DNA molecules, we must follow the provisions set forth in the NIH Guidelines for Research Involving Recombinant DNA Molecules ( NIH Guidelines ).
Compliance with these guidelines is critical to insure the safe conduct of research and fulfullment of our institutional commitment to protect staff, the environment, and public health.
On behalf of Florida Institute of Technology, the principal investigator (PI) is responsible for compliance with all NIH regulations contained in the guidelines. The PI should first determine if their experiments are covered by the NIH guidelines or are exempt from them.
If the experiments are covered by the guidelines the PI should complete the Recombinant DNA Registration Form and comply with all guidelines and applicable campus policies and procedures.
David Carroll, Assistant Director. dcarroll@fit.edu. 321-674-7133
Julia Grimwade, Associate Professor. grimwade@fit.edu. 321-674-7152
Alan Leonard, Professor. aleonard@fit.edu. 321-674-8577
Charles Polson, Associate Professor. cpolson@fit.edu. 321-674-7480
Gary Wells, Professor/Department Head. gwells@fit.edu. 321-674-8034
Florida Tech Recombinant DNA Registration Form ( PDF )
Related Links
NIH Recombinant DNA Guidelines at the National Institute of Health
|
